ARCHIVES

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

NCI’s Share Of Gramm-Rudman Cuts For FY 1986 Is $54 Million; Staff Ponders How To Absorb It

January 24, 1986

Called “Unscrupulous” in Abramson Lawsuit, Thompson Calls Abramson A Rich Man Scorned

March 23, 2012

RFP: Sole Source

May 12, 2000

New Treatments And Quality of Life Study For Ovarian Cancer Described At SGO

March 26, 2004

Zometa Can Reduce Risk Of Skeletal-Related Events

August 26, 2011

USC Cancer Center Plans Expansion, Gets New Name

January 27, 1989